Host cell-type and pathogen-specific immunomodulatory functions of macrophage migration inhibitory factor (MIF) in infectious keratitis

被引:2
|
作者
Ghosh, Swagata [1 ]
Khathun, A. H. Humera [1 ]
Athulya, G. S. [1 ]
Vignesh, P. [1 ]
Mathan, L. [2 ]
Mudaraddi, Ninad [3 ]
Narendran, Siddharth [1 ,4 ]
Lalitha, Prajna [5 ]
Prajna, N. Venkatesh [3 ]
机构
[1] Aravind Med Res Fdn, Dept Microbiol, Madurai, India
[2] Aravind Med Res Fdn, Dept Prote, Madurai, India
[3] Aravind Eye Hosp, Dept Cornea & Refract Surg, Madurai, India
[4] Aravind Eye Hosp, Coimbatore, India
[5] Aravind Eye Hosp, Dept Ocular Microbiol, Madurai, India
关键词
Infectious keratitis; Inflammatory response; Immunomodulation; Macrophage migration inhibitory factor; Aspergillus flavus; Acanthamoeba castellanii; Corneal infection; ASPERGILLUS-FUMIGATUS CONIDIA; CORNEAL EPITHELIAL-CELLS; ACANTHAMOEBA-KERATITIS; IMMUNE-RESPONSE; INNATE IMMUNITY; POTENTIAL ROLE; IN-VITRO; IDENTIFICATION; DIAGNOSIS; FUSARIUM;
D O I
10.1016/j.exer.2023.109669
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Therapeutic management of inflammation in infectious keratitis (IK) requires new strategy and targets for selective immunomodulation. Targeting host cell-type specific inflammatory responses might be a viable strategy to curtail unnecessary inflammation and reduce tissue damage without affecting pathogen clearance. This study explores the possibility of pathogen and host cell-type dependent differences in the inflammatory pathways relevant in the pathogenesis of IK. Human corneal epithelial cell line (HCEC) and phorbol 12-myristate-13 acetate (PMA) differentiated THP-1 macrophage line were infected with either Aspergillus flavus conidia or Acanthamoeba castellanii trophozoites and the elicited inflammatory responses were studied in terms of gene expression and secretion of proinflammatory factors interleukin-8 (IL-8) and tumor necrosis factor-alpha (TNF-alpha) and an upstream inflammatory regulator and mediator protein-the Macrophage Migration Inhibitory Factor (MIF). Given the pleotropic mode of MIF function in diverse cell types relevant in many human diseases, we tested if MIF driven responses to infection is different in HCECs and THP-1 macrophages by studying its expression, secretion and involvement in inflammation by siRNA mediated knockdown. We also examined IK patient tear samples for MIF levels. Infection with A. flavus or A. castellanii induced IL-8 and TNF-alpha responses in HCECs and THP-1 macrophages but to different levels. Our preliminary human data showed that the level of secreted MIF protein was elevated in IK patient tear, however, MIF secretion by the two cell types were strikingly different in-vitro, under both normal and infected conditions. We found that HCECs released MIF constitutively, which was significantly inhibited with infection, whereas THP-1 macrophages were stimulated to release MIF during infection. MIF gene expression remained largely unaffected by infection in both the cell lines. Although MIF in HCECs appeared to be intracellularly captured during infection, MIF knockdown in HCECs associated with a partial reduction of the IL-8 and TNF-alpha expression produced by either of the pathogens, suggesting a proinflammatory role for MIF in HCECs, independent of its canonical cytokine like function. In contrast, MIF knockdown in THP-1 macrophages accompanied a dramatic increase in IL-8 and TNF-alpha expression during A. castellanii infection, while the responses to A. flavus infection remained unchanged. These data imply a host cell-type and pathogen specific distinction in the MIF- related inflammatory signaling and MIF as a potential selective immunomodulatory target in infectious keratitis.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] Transcriptional profiling specifies the pathogen-specific human host response to infectious keratitis
    Lapp, Thabo
    Kammrath Betancor, Paola
    Schlunck, Guenther
    Auw-Haedrich, Claudia
    Maier, Philip
    Lange, Clemens
    Reinhard, Thomas
    Wolf, Julian
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2024, 13
  • [2] Macrophage migration inhibitory factor (MIF) and cell differentiation
    Kobayashi, S
    Yoshida, K
    Longenecker, G
    Satomura, K
    Levsky, JM
    Semba, I
    Sreenath, T
    Wistow, GJ
    Shum, L
    Slavkin, HC
    Kulkarni, AB
    MOLECULAR BIOLOGY OF THE CELL, 1998, 9 : 437A - 437A
  • [3] Glucocorticoids suppress macrophage migration inhibitory factor (MIF) expression in a cell-type-specific manner
    Alourfi, Z
    Donn, RP
    Stevens, A
    Berry, A
    McMaster, A
    Ray, DW
    JOURNAL OF MOLECULAR ENDOCRINOLOGY, 2005, 34 (02) : 583 - 595
  • [4] Identification of a novel cell type specific intronic enhancer of macrophage migration inhibitory factor (MIF) and its regulation by mithramycin
    Green, Laura
    Beaulieu, Elaine
    Elsby, Laura
    Alourfi, Zaynab
    Ray, David W.
    Donn, Rachelle P.
    RHEUMATOLOGY, 2008, 47 : II56 - II56
  • [5] Macrophage migration inhibitory factor (MIF) is critical for the host resistance against Toxoplasma gondii
    Flores, Marcos
    Saavedra, Rafael
    Bautista, Rocio
    Viedma, Rubi
    Tenorio, Eda P.
    Leng, Lin
    Sanchez, Yuriko
    Juarez, Imelda
    Satoskar, Anjali A.
    Shenoy, Asha S.
    Terrazas, Luis I.
    Bucala, Richard
    Barbi, Joseph
    Satoskar, Abhay R.
    Rodriguez-Sosa, Miriam
    FASEB JOURNAL, 2008, 22 (10): : 3661 - 3671
  • [6] Identification of a novel cell type-specific intronic enhancer of macrophage migration inhibitory factor (MIF) and its regulation by mithramycin
    Beaulieu, E.
    Green, L.
    Elsby, L.
    Alourfi, Z.
    Morand, E. F.
    Ray, D. W.
    Donn, R.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2011, 163 (02): : 178 - 188
  • [7] The β-cell expression of the macrophage migration inhibitory factor MIF is transcriptionally regulated by glucose
    Thompson, N
    Nicod, P
    Waeber, G
    DIABETES, 1999, 48 : A184 - A184
  • [8] Involvement of macrophage migration inhibitory factor (MIF) in the mechanism of tumor cell growth
    Takahashi, N
    Nishihira, J
    Sato, Y
    Kondo, M
    Ogawa, H
    Ohshima, T
    Une, Y
    Todo, S
    MOLECULAR MEDICINE, 1998, 4 (11) : 707 - 714
  • [9] Involvement of Macrophage Migration Inhibitory Factor (MIF) in the Mechanism of Tumor Cell Growth
    Norihiko Takahashi
    Jun Nishihira
    Yuji Sato
    Masao Kondo
    Hideaki Ogawa
    Takahiro Ohshima
    Yoshie Une
    Satoru Todo
    Molecular Medicine, 1998, 4 : 707 - 714
  • [10] Macrophage Migration Inhibitory Factor (MIF) Is Essential for Type 2 Effector Cell Immunity to an Intestinal Helminth Parasite
    Filbey, Kara J.
    Varyani, Fumi
    Harcus, Yvonne
    Hewitson, James P.
    Smyth, Danielle J.
    McSorley, Henry J.
    Ivens, Alasdair
    Nylen, Susanne
    Rottenberg, Martin
    Loser, Stephan
    Maizels, Rick M.
    FRONTIERS IN IMMUNOLOGY, 2019, 10